Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients

Clicks: 457
ID: 120122
1995
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Star

Ranked #4 of 23 articles by views in bone marrow transplantation

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Respiratory syncytial virus (RSV) infections in adult BMT recipients are frequently complicated by fatal pneumonias. Therapy of RSV pneumonia with aerosolized ribavirin alone has been reported to be associated with a 70% mortality rate. Because immune globulin therapy has been reported to be benefic …
Reference Key
e1995bonecombination Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Whimbey E;Champlin RE;Englund JA;Mirza NQ;Piedra PA;Goodrich JM;Przepiorka D;Luna MA;Morice RC;Neumann JL;;
Journal bone marrow transplantation
Year 1995
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/8535312
Keywords
Administration National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine adult male middle aged Clinical Trial immunoglobulins intravenous / therapeutic use* inhalation Survival Analysis respiratory syncytial viruses / isolation & purification* drug therapy combination r e champlin e whimbey antiviral agents / therapeutic use* ribavirin / administration & dosage ribavirin / therapeutic use* respiratory syncytial virus infections / drug therapy* respiratory syncytial virus infections / mortality cross infection / mortality bone marrow transplantation / adverse effects* respiratory syncytial virus infections / etiology cross infection / drug therapy* pmid:8535312 j l neumann

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.